|
Index of reports
> Life Threatening Events (29)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Rituxan (Rituximab) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Rituxan side effects in 81 year old male
Reported by a health professional (non-physician/pharmacist) from Australia on 2012-08-22
Patient: 81 year old male
Reactions: Vision Blurred, Neutropenia, Thrombocytopenia, Fall, Leukopenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Rituxan
Possible Rituxan side effects in
Reported by a physician from China on 2012-08-14
Patient:
Reactions: Dyspnoea, Hyperpyrexia, Tachycardia, Oliguria, Altered State of Consciousness, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Rituxan
Possible Rituxan side effects in 1 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-25
Patient: 1 year old male, weighing 18.0 kg (39.6 pounds)
Reactions: Pneumonia Fungal, Electrocardiogram QT Prolonged, Renal Disorder, Malnutrition, Disseminated Intravascular Coagulation, Clostridium Colitis, Gastric Ulcer, Pneumonia Cytomegaloviral, Liver Disorder, Hypokalaemia, Pneumocystis Jiroveci Pneumonia, Pneumonia Bacterial, Pancreatitis, Acute Respiratory Distress Syndrome
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Ambisome
Dosage: uncertainty
Bactrim
Dosage: unk
Cellcept
Dosage: uncertainty
Administration route: Oral
Cyclosporine
Dosage: uncertainty
Decadron
Dosage: 12 mg, unk
Administration route: Oral
Indication: Idiopathic Thrombocytopenic Purpura
Start date: 2011-05-20
End date: 2011-06-17
Funguard
Dosage: uncertainty
Meropenem
Dosage: unk
Indication: Prophylaxis
Rituxan
Romiplostim
Dosage: 1 mg/kg, qwk
Indication: Idiopathic Thrombocytopenic Purpura
Start date: 2011-06-01
End date: 2011-06-08
Romiplostim
Dosage: 2 mg/kg, qwk
Start date: 2011-06-15
End date: 2011-06-15
Romiplostim
Dosage: 3 mg/kg, qwk
Start date: 2011-06-24
End date: 2012-06-24
Romiplostim
Dosage: 5 mg/kg, qwk
Start date: 2011-08-09
End date: 2011-08-09
Romiplostim
Dosage: 5 mg/kg, qwk
Start date: 2011-07-21
End date: 2011-08-06
Romiplostim
Dosage: 10 mg/kg, qwk
Start date: 2011-10-17
Romiplostim
Dosage: 9 mg/kg, qwk
Start date: 2011-09-08
End date: 2011-09-08
Romiplostim
Dosage: 4 mg/kg, qwk
Start date: 2011-07-11
End date: 2011-07-11
Romiplostim
Dosage: 8 mg/kg, qwk
Start date: 2011-09-01
End date: 2011-09-01
Romiplostim
Dosage: 3 mg/kg, qwk
Start date: 2012-06-21
End date: 2012-06-21
Romiplostim
Dosage: 6 mg/kg, qwk
Start date: 2011-08-16
End date: 2011-08-16
Romiplostim
Dosage: 7 mg/kg, qwk
Start date: 2011-08-24
End date: 2011-08-24
Romiplostim
Dosage: 10 mg/kg, qwk
Start date: 2011-09-15
End date: 2011-10-13
Zosyn
Dosage: unk
Other drugs received by patient: Prednisolone; Prednisolone; Fungizone; Prednisolone; Prednisolone; Prednisolone; Famotidine; Danazol; Danazol; Immune Globulin (Human); Cefazolin Sodium; Prednisolone; Prednisolone; Prednisolone; Prednisolone
Possible Rituxan side effects in 1 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-13
Patient: 1 year old male, weighing 18.0 kg (39.6 pounds)
Reactions: Electrocardiogram QT Prolonged, Pneumonia Fungal, Renal Disorder, Disseminated Intravascular Coagulation, Malnutrition, Gastric Ulcer, Clostridium Colitis, Pneumonia Cytomegaloviral, Hypokalaemia, Liver Disorder, Pneumocystis Jiroveci Pneumonia, Pneumonia Bacterial, Pancreatitis, Acute Respiratory Distress Syndrome
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Ambisome
Dosage: uncertainty
Bactrim
Dosage: unk
Cellcept
Dosage: uncertainty
Administration route: Oral
Cyclosporine
Dosage: uncertainty
Decadron
Dosage: 12 mg, unk
Administration route: Oral
Indication: Idiopathic Thrombocytopenic Purpura
Start date: 2011-05-20
End date: 2011-06-17
Funguard
Dosage: uncertainty
Meropenem
Dosage: unk
Indication: Prophylaxis
Rituxan
Romiplostim
Dosage: 3 mg/kg, qwk
Start date: 2011-06-24
End date: 2012-06-24
Romiplostim
Dosage: 10 mg/kg, qwk
Start date: 2011-09-15
End date: 2011-10-13
Romiplostim
Dosage: 2 mg/kg, qwk
Start date: 2011-06-15
End date: 2011-06-15
Romiplostim
Dosage: 5 mg/kg, qwk
Start date: 2011-07-21
End date: 2011-08-06
Romiplostim
Dosage: 6 mg/kg, qwk
Start date: 2011-08-16
End date: 2011-08-16
Romiplostim
Dosage: 5 mg/kg, qwk
Start date: 2011-08-09
End date: 2011-08-09
Romiplostim
Dosage: 10 mg/kg, qwk
Start date: 2011-10-17
Romiplostim
Dosage: 8 mg/kg, qwk
Start date: 2011-09-01
End date: 2011-09-01
Romiplostim
Dosage: 9 mg/kg, qwk
Start date: 2011-09-08
End date: 2011-09-08
Romiplostim
Dosage: 4 mg/kg, qwk
Start date: 2011-07-11
End date: 2011-07-11
Romiplostim
Dosage: 1 mg/kg, qwk
Indication: Idiopathic Thrombocytopenic Purpura
Start date: 2011-06-01
End date: 2011-06-08
Romiplostim
Dosage: 3 mg/kg, qwk
Start date: 2012-06-21
End date: 2012-06-21
Romiplostim
Dosage: 7 mg/kg, qwk
Start date: 2011-08-24
End date: 2011-08-24
Zosyn
Dosage: unk
Other drugs received by patient: Danazol; Famotidine; Prednisolone; Prednisolone; Danazol; Prednisolone; Cefazolin Sodium; Prednisolone; Immune Globulin (Human); Prednisolone; Fungizone; Prednisolone; Prednisolone; Prednisolone; Prednisolone
Possible Rituxan side effects in 54 year old male
Reported by a pharmacist from Canada on 2012-07-10
Patient: 54 year old male
Reactions: White Blood Cell Count Decreased, Peritonitis Bacterial, Hypotension, Hernial Eventration, Neutropenia, Septic Shock, Respiratory Distress, Loss of Consciousness
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Product Used FOR Unknown Indication
Doxorubicin Hydrochloride
Indication: Product Used FOR Unknown Indication
Rituxan
Indication: Product Used FOR Unknown Indication
Vincristine Sulfate
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Fluconazole; Furosemide; Nadolol; Omeprazole; Amiloride Hydrochloride; Ciprofloxacin; Acyclovir; Lactulose
Possible Rituxan side effects in 66 year old female
Reported by a physician from Canada on 2012-07-06
Patient: 66 year old female
Reactions: Cerebral Disorder, Progressive Multifocal Leukoencephalopathy
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Rituxan
Other drugs received by patient: Prednisone; Calcium / Vitamin D; Fosamax
Possible Rituxan side effects in 41 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-25
Patient: 41 year old female
Reactions: Drug Ineffective, Progressive Multifocal Leukoencephalopathy
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Infliximab
Indication: Dermatomyositis
Start date: 2008-03-13
End date: 2008-08-21
Methotrexate
Indication: Dermatomyositis
Start date: 2006-06-01
Prednisone TAB
Administration route: Oral
Indication: Dermatomyositis
Start date: 2006-05-01
Rituxan
Dosage: on days 1 and 15
Start date: 2008-10-13
Rituxan
Indication: Dermatomyositis
Start date: 2009-08-13
Rituxan
Dosage: this was the last dose prior to sae onset lot numbers for this dose was 720648, 720649.
Start date: 2008-10-27
Rituxan
Dosage: one days 1 and 15
Start date: 2007-07-01
Other drugs received by patient: Tramadol Hydrochl; Hydrochlorothiazide; Actonel; Folic Acid
Possible Rituxan side effects in male
Reported by a physician from United States on 2012-06-05
Patient: male, weighing 79.0 kg (173.8 pounds)
Reactions: Central Nervous System Lymphoma
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Rituxan
Other drugs received by patient: Methotrexate
Possible Rituxan side effects in 61 year old male
Reported by a physician from Canada on 2012-05-22
Patient: 61 year old male, weighing 99.0 kg (217.8 pounds)
Reactions: Sick Sinus Syndrome
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Rituxan
Possible Rituxan side effects in 61 year old male
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-05-11
Patient: 61 year old male, weighing 124.0 kg (272.8 pounds)
Reactions: Pneumonia Primary Atypical, Febrile Neutropenia, Septic Shock, Respiratory Syncytial Virus Infection
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Bendamustine Hydrochloride
Dosage: 127 milligram
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-03-15
End date: 2012-03-15
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-03-15
End date: 2012-04-11
Rituxan
Dosage: 953.9 milligram
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-03-14
End date: 2012-03-14
Other drugs received by patient: Hydrochlorothiazide; Tamsulosin HCL; Gabapentin; Rifabutin; Ethambutol Hydrochloride; Amphotericin B; Indapamid; Candesartan Cilexetil; Tiotropium; Fluticasone Propionate / Salmeterol; Pantoprazole; Amlodipine Besylate; Torsemide; Acetylsalicylic Acid SRT; Metoprolol Tartrate; Tilidin Plus; Rifabutin; Metformin HCL; Clarithromycin; Digitoxin TAB
Possible Rituxan side effects in 62 year old male
Reported by a pharmacist from Canada on 2012-04-26
Patient: 62 year old male, weighing 60.0 kg (132.0 pounds)
Reactions: Dyspnoea, Angioedema, Laryngeal Stenosis, Dysphagia, Swelling, Endotracheal Intubation, Enlarged Uvula
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Rituxan
Other drugs received by patient: Doxazosin Mesylate; Vincristine; Omeprazole; Prednisone TAB; Ondansetron; Cyclophosphamide; Diphenhydramine HCL; Acetaminophen; Dexamethasone; Doxorubicin Hydrochloride; Prochlorperazine; Zopiclone; Amiodarone HCL; Celebrex; Lyrica; Travatan
Possible Rituxan side effects in 59 year old female
Reported by a physician from Canada on 2012-04-25
Patient: 59 year old female, weighing 42.2 kg (92.9 pounds)
Reactions: Breast Cancer, Weight Decreased, Fatigue, Anaemia, Breast Cancer in Situ
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Methotrexate
Indication: Product Used FOR Unknown Indication
Rituxan
Indication: Product Used FOR Unknown Indication
Possible Rituxan side effects in 41 year old female
Reported by a physician from United States on 2012-04-24
Patient: 41 year old female
Reactions: Drug Ineffective, Progressive Multifocal Leukoencephalopathy
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Infliximab
Indication: Dermatomyositis
Start date: 2008-03-13
End date: 2008-08-21
Methotrexate
Indication: Dermatomyositis
Start date: 2006-06-01
Prednisone TAB
Administration route: Oral
Indication: Dermatomyositis
Start date: 2006-05-01
Rituxan
Indication: Dermatomyositis
Start date: 2009-08-13
Rituxan
Dosage: on days 1 and 15
Start date: 2008-10-13
Rituxan
Dosage: one days 1 and 15
Start date: 2007-07-01
Rituxan
Dosage: this was the last dose prior to sae onset lot numbers for this dose was 720648, 720649.
Start date: 2008-10-27
Other drugs received by patient: Actonel; Folic Acid; Hydrochlorothiazide; Tramadol Hydrochl
Possible Rituxan side effects in
Reported by a consumer/non-health professional from United States on 2012-04-12
Patient:
Reactions: Adverse Reaction
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Rituxan
Possible Rituxan side effects in 63 year old female
Reported by a pharmacist from Canada on 2012-04-10
Patient: 63 year old female
Reactions: Pneumocystis Jiroveci Pneumonia, Respiratory Failure, Neutropenia, Cognitive Disorder, Thrombocytopenia, Leukopenia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Rituxan
Dosage: (the patient received rituximab on 13 january 2012).
Start date: 2011-12-30
Rituxan
Dosage: (the patient received rituximab on 21 july 2011, 25 july 2011 and 27 july 2011).
Indication: Epstein-Barr Virus Infection
Start date: 2011-07-19
Other drugs received by patient: Proctosone; Cefazolin; Ceftazidime; Albuterol; Primaquine; Levofloxacin; Lansoprazole; Piperacillin and Tazobactam; Nabilone; Prednisone TAB; Hydromorphone HCL; Ipratropium Bromide; Clindamycin; Nystatin; Solu-Medrol
Possible Rituxan side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-29
Patient: male, weighing 77.4 kg (170.3 pounds)
Reactions: Metastatic Neoplasm, Refusal of Treatment by Patient, Coombs Positive Haemolytic Anaemia, Burkitt's Lymphoma, Ascites, Treatment Related Secondary Malignancy
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 600 mg/m2 on weeks, 1,5,9,13,17 and 21, intraveous (not otherwise specified)
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-06-16
End date: 2008-11-17
Pentostatin
Dosage: 4 mg/m2 x 1 day weeks, 1,5,9,13,17 and 21, intravenous (not otherwise specified)
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-06-16
End date: 2008-11-17
Rituxan
Dosage: 375 mg/m2 over 4 hr/on one day on weeks 1,5,9,13,17 and 21, intravaneous (not otherwise specified)
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-06-16
End date: 2008-11-17
Possible Rituxan side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-15
Patient: male, weighing 77.4 kg (170.3 pounds)
Reactions: Abdominal Pain, Economic Problem, Refusal of Treatment by Patient, Anaemia Haemolytic Autoimmune, Burkitt's Lymphoma, Metastases To Pelvis, Ascites, Treatment Related Secondary Malignancy, Chronic Lymphocytic Leukaemia Recurrent, Metastases To Peritoneum, Neutropenia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 600 mg/m2 on weeks 1,5,9,13,17 and 21, (unknown) intravenous (not otherwise specified)
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-06-16
End date: 2008-11-17
Pentostatin
Dosage: 4mg/m2 x 1 day weeks 1,5,9,13,17 and 21, (unknown) intravenous (not otherwise specified)
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-06-16
End date: 2008-11-17
Rituxan
Dosage: 375 mg/m2 over 4 hr/on one day on weeks 1, 5, 9, 13,17 and 21 (unknown) intravenous (not otherwise s
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-06-16
End date: 2008-11-17
Possible Rituxan side effects in 55 year old female
Reported by a individual with unspecified qualification from United States on 2012-03-02
Patient: 55 year old female
Reactions: Pneumonia, Hypogammaglobulinaemia, Sinusitis
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Vasculitis
Prednisone TAB
Indication: Vasculitis
Rituxan
Indication: Vasculitis
Other drugs received by patient: Azathioprine
Possible Rituxan side effects in female
Reported by a physician from United States on 2012-02-27
Patient: female
Reactions: Progressive Multifocal Leukoencephalopathy
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Rituxan
Other drugs received by patient: Anastrole
Possible Rituxan side effects in female
Reported by a physician from United Kingdom on 2012-02-27
Patient: female, weighing 84.5 kg (185.9 pounds)
Reactions: Diarrhoea, Mouth Ulceration, Neutropenic Sepsis, Lymphopenia, Anaemia, Pyrexia, Neutropenia, Lethargy
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: B-Cell Lymphoma
Prednisolone
Indication: B-Cell Lymphoma
Rituxan
Rituxan
Indication: B-Cell Lymphoma
Start date: 2010-05-20
Vincristine
Indication: B-Cell Lymphoma
Other drugs received by patient: Acetaminophen; Chlorpheniramine Maleate; Cotrim
Possible Rituxan side effects in female
Reported by a physician from United States on 2012-02-20
Patient: female
Reactions: Extrasystoles, Erythema, Weight Increased, Fatigue, Dizziness, Sneezing, Cold Sweat, Cardiac Failure Congestive, Fluid Overload, Blood Pressure Increased, Dyspnoea, Chest Discomfort, Tremor, Paraesthesia, Alopecia, Heart Rate Increased, Major Depression, Asthenia, Infusion Related Reaction
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Hypericum Perforatum
Dosage: reported: st john's wort
Indication: Major Depression
Rituxan
Indication: Rheumatoid Arthritis
Start date: 2009-02-01
Other drugs received by patient: Calcium; Vitamin D; Potassium Chloride; Aspirin; Fish OIL; Levothyroxine Sodium; Folic Acid; Vitamin B Complex CAP; Simvastatin; Arava; Magnesium; Lasix; Prevacid
Possible Rituxan side effects in female
Reported by a physician from United States on 2012-02-20
Patient: female
Reactions: Progressive Multifocal Leukoencephalopathy
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Rituxan
Other drugs received by patient: Anastrozole; Cisplatin; Paclitaxel; Carboplatin
Possible Rituxan side effects in female
Reported by a physician from United States on 2011-12-30
Patient: female
Reactions: Progressive Multifocal Leukoencephalopathy
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Rituxan
Other drugs received by patient: Anastrole
Possible Rituxan side effects in female
Reported by a physician from United States on 2011-12-23
Patient: female
Reactions: Progressive Multifocal Leukoencephalopathy
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Rituxan
Other drugs received by patient: Carboplatin; Paclitaxel; Anastrozole; Cisplatin
Possible Rituxan side effects in male
Reported by a physician from United States on 2011-12-20
Patient: male, weighing 108.0 kg (237.6 pounds)
Reactions: Neutropenic Infection, Sepsis, Lymphopenia, Hypocalcaemia, Pancytopenia, Blood Sodium Abnormal, Blood Glucose Abnormal
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Cyclophosphamide
End date: 2010-08-15
Cyclophosphamide
Indication: Burkitt's Lymphoma Stage IV
Cyclophosphamide
Start date: 2010-05-14
Cytarabine
End date: 2010-08-15
Cytarabine
Indication: Burkitt's Lymphoma Stage IV
Cytarabine
Start date: 2010-05-14
Cytarabine
Doxorubicin HCL
End date: 2010-08-15
Doxorubicin HCL
Doxorubicin HCL
Doxorubicin HCL
Indication: Burkitt's Lymphoma Stage IV
Start date: 2010-05-14
Etoposide
End date: 2010-08-15
Etoposide
Etoposide
Indication: Burkitt's Lymphoma Stage IV
Etoposide
Start date: 2010-05-14
Filgrastim
Start date: 2010-05-14
Filgrastim
Indication: Burkitt's Lymphoma Stage IV
Filgrastim
End date: 2010-08-15
Filgrastim
Ifosfamide
Start date: 2010-05-14
Ifosfamide
End date: 2010-08-15
Ifosfamide
Ifosfamide
Indication: Burkitt's Lymphoma Stage IV
Leucovorin Calcium
Start date: 2010-05-14
Leucovorin Calcium
Leucovorin Calcium
Indication: Burkitt's Lymphoma Stage IV
End date: 2010-08-15
Leucovorin Calcium
Methotrexate
Indication: Burkitt's Lymphoma Stage IV
End date: 2010-08-15
Methotrexate
Methotrexate
Methotrexate
Start date: 2010-05-14
Rituxan
Indication: Burkitt's Lymphoma
Start date: 2010-05-14
Rituxan
End date: 2010-08-15
Rituxan
Rituxan
Vincristine
Vincristine
Vincristine
Indication: Burkitt's Lymphoma Stage IV
End date: 2010-08-15
Vincristine
Start date: 2010-05-14
Possible Rituxan side effects in 81 year old female
Reported by a physician from United States on 2011-12-07
Patient: 81 year old female
Reactions: Progressive Multifocal Leukoencephalopathy
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Rituxan
Possible Rituxan side effects in female
Reported by a consumer/non-health professional from United States on 2011-12-05
Patient: female
Reactions: Extrasystoles, Erythema, Weight Increased, Fatigue, Dizziness, Sneezing, Cold Sweat, Cardiac Failure Congestive, Fluid Overload, Blood Pressure Increased, Chest Discomfort, Dyspnoea, Paraesthesia, Tremor, Alopecia, Heart Rate Increased, Major Depression, Asthenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Rituxan
Other drugs received by patient: Vitamin B Complex CAP; Magnesium Sulfate; Potassium Acetate; Fish OIL; Folic Acid; Simvastatin; Calcium; Vitamin D; Arava; Aspirin; Lasix; Levothyroxine Sodium; Prevacid
Possible Rituxan side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-09
Patient: female, weighing 70.3 kg (154.7 pounds)
Reactions: Oedema Peripheral, Dizziness, Atrial Fibrillation, Mobility Decreased
Adverse event resulted in: life threatening event, disablity
Drug(s) suspected as cause:
Rituxan
Dosage: i.v.
Indication: Rheumatoid Arthritis
Start date: 2009-07-06
Rituxan
Dosage: i.v.
Indication: Rheumatoid Arthritis
Start date: 2009-06-18
Possible Rituxan side effects in 81 year old female
Reported by a physician from United States on 2011-10-17
Patient: 81 year old female
Reactions: Progressive Multifocal Leukoencephalopathy
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Rituxan
|
